Silke Gillessen
Silke Gillessen, MD
Silke Gillessen is the Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester, UK, and Honorary Consultant at The Christie Hospital in Manchester. She is a consultant in the Department of Oncology/Haematology at the Kantonsspital St. Gallen, Switzerland; Head of the Department of Medical Oncology and Professor at the Università della Svizzera Italiana (USI) in Lugano; and Director of the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona, Switzerland.
Disclosures: Consultation/speaking/travel fees from AAA International, Amgen, AstraZeneca, Astellas, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, InnoMedica, Ipsen, Meister-ConCept, Modra Pharmaceuticals, MSD, Myriad Genetic, Novartis, Orion, Pfizer, Roche, and Telix Pharmaceuticals. Patent for a research method for biomarker WO2009138392.
View content featuring Gillessen:
• ASCO GU 2025: Advances in radiation therapy for prostate cancer metastases
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
of interest
are looking at
saved
next event